NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION

The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROUAUD SYLVIE, MEVELEC LAURENCE, GILET CHRYSTELLE, CAVOLEAU SYLVIE, POUTOT SANDRINE, CHARBONNEL SANDRA, ROBIN JEAN-PIERRE, DHAL ROBERT, FOURNIER FLORENCE, DUJARDIN GILLES, ROBIN JULIE, CHAUVIAT LUDOVIC, GIRODIER LAURENT
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ROUAUD SYLVIE
MEVELEC LAURENCE
GILET CHRYSTELLE
CAVOLEAU SYLVIE
POUTOT SANDRINE
CHARBONNEL SANDRA
ROBIN JEAN-PIERRE
DHAL ROBERT
FOURNIER FLORENCE
DUJARDIN GILLES
ROBIN JULIE
CHAUVIAT LUDOVIC
GIRODIER LAURENT
description The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine), in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL343032A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL343032A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL343032A13</originalsourceid><addsrcrecordid>eNrjZHD08w9z9VFwdg3wcPTxD3GMcPRzVXBxDfIMcwzxDHMNVnD0c1EICPJ3dg0OVnDzD1II8XD1DAKKuAY4BgGV-PvxMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JL4AB9jE2MDYyNHQ2PCKgBNmipb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION</title><source>esp@cenet</source><creator>ROUAUD SYLVIE ; MEVELEC LAURENCE ; GILET CHRYSTELLE ; CAVOLEAU SYLVIE ; POUTOT SANDRINE ; CHARBONNEL SANDRA ; ROBIN JEAN-PIERRE ; DHAL ROBERT ; FOURNIER FLORENCE ; DUJARDIN GILLES ; ROBIN JULIE ; CHAUVIAT LUDOVIC ; GIRODIER LAURENT</creator><creatorcontrib>ROUAUD SYLVIE ; MEVELEC LAURENCE ; GILET CHRYSTELLE ; CAVOLEAU SYLVIE ; POUTOT SANDRINE ; CHARBONNEL SANDRA ; ROBIN JEAN-PIERRE ; DHAL ROBERT ; FOURNIER FLORENCE ; DUJARDIN GILLES ; ROBIN JULIE ; CHAUVIAT LUDOVIC ; GIRODIER LAURENT</creatorcontrib><description>The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine), in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.</description><edition>7</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20010730&amp;DB=EPODOC&amp;CC=PL&amp;NR=343032A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20010730&amp;DB=EPODOC&amp;CC=PL&amp;NR=343032A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROUAUD SYLVIE</creatorcontrib><creatorcontrib>MEVELEC LAURENCE</creatorcontrib><creatorcontrib>GILET CHRYSTELLE</creatorcontrib><creatorcontrib>CAVOLEAU SYLVIE</creatorcontrib><creatorcontrib>POUTOT SANDRINE</creatorcontrib><creatorcontrib>CHARBONNEL SANDRA</creatorcontrib><creatorcontrib>ROBIN JEAN-PIERRE</creatorcontrib><creatorcontrib>DHAL ROBERT</creatorcontrib><creatorcontrib>FOURNIER FLORENCE</creatorcontrib><creatorcontrib>DUJARDIN GILLES</creatorcontrib><creatorcontrib>ROBIN JULIE</creatorcontrib><creatorcontrib>CHAUVIAT LUDOVIC</creatorcontrib><creatorcontrib>GIRODIER LAURENT</creatorcontrib><title>NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION</title><description>The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine), in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD08w9z9VFwdg3wcPTxD3GMcPRzVXBxDfIMcwzxDHMNVnD0c1EICPJ3dg0OVnDzD1II8XD1DAKKuAY4BgGV-PvxMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JL4AB9jE2MDYyNHQ2PCKgBNmipb</recordid><startdate>20010730</startdate><enddate>20010730</enddate><creator>ROUAUD SYLVIE</creator><creator>MEVELEC LAURENCE</creator><creator>GILET CHRYSTELLE</creator><creator>CAVOLEAU SYLVIE</creator><creator>POUTOT SANDRINE</creator><creator>CHARBONNEL SANDRA</creator><creator>ROBIN JEAN-PIERRE</creator><creator>DHAL ROBERT</creator><creator>FOURNIER FLORENCE</creator><creator>DUJARDIN GILLES</creator><creator>ROBIN JULIE</creator><creator>CHAUVIAT LUDOVIC</creator><creator>GIRODIER LAURENT</creator><scope>EVB</scope></search><sort><creationdate>20010730</creationdate><title>NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION</title><author>ROUAUD SYLVIE ; MEVELEC LAURENCE ; GILET CHRYSTELLE ; CAVOLEAU SYLVIE ; POUTOT SANDRINE ; CHARBONNEL SANDRA ; ROBIN JEAN-PIERRE ; DHAL ROBERT ; FOURNIER FLORENCE ; DUJARDIN GILLES ; ROBIN JULIE ; CHAUVIAT LUDOVIC ; GIRODIER LAURENT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL343032A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROUAUD SYLVIE</creatorcontrib><creatorcontrib>MEVELEC LAURENCE</creatorcontrib><creatorcontrib>GILET CHRYSTELLE</creatorcontrib><creatorcontrib>CAVOLEAU SYLVIE</creatorcontrib><creatorcontrib>POUTOT SANDRINE</creatorcontrib><creatorcontrib>CHARBONNEL SANDRA</creatorcontrib><creatorcontrib>ROBIN JEAN-PIERRE</creatorcontrib><creatorcontrib>DHAL ROBERT</creatorcontrib><creatorcontrib>FOURNIER FLORENCE</creatorcontrib><creatorcontrib>DUJARDIN GILLES</creatorcontrib><creatorcontrib>ROBIN JULIE</creatorcontrib><creatorcontrib>CHAUVIAT LUDOVIC</creatorcontrib><creatorcontrib>GIRODIER LAURENT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROUAUD SYLVIE</au><au>MEVELEC LAURENCE</au><au>GILET CHRYSTELLE</au><au>CAVOLEAU SYLVIE</au><au>POUTOT SANDRINE</au><au>CHARBONNEL SANDRA</au><au>ROBIN JEAN-PIERRE</au><au>DHAL ROBERT</au><au>FOURNIER FLORENCE</au><au>DUJARDIN GILLES</au><au>ROBIN JULIE</au><au>CHAUVIAT LUDOVIC</au><au>GIRODIER LAURENT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION</title><date>2001-07-30</date><risdate>2001</risdate><abstract>The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine), in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_PL343032A1
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NOVEL CEPHALOTAXANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T12%3A22%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROUAUD%20SYLVIE&rft.date=2001-07-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL343032A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true